Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 16/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.34 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.34 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.34 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.34 |
| ▸ | METTL3 | Q86U44 | 1/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7006064 | 0.83 | ELANE (0.75) | ELANETDP1 | |
| SCHEMBL7003649 | 0.74 | ELANE (0.52) | ELANE | |
| SCHEMBL7010118 | 0.73 | ELANE (0.72) | ELANETDP1 | |
| SCHEMBL7388768 | 0.72 | ELANE (0.51) | ELANE | |
| SCHEMBL7287616 | 0.68 | ELANE (0.72) | ELANE | |
| SCHEMBL9149524 | 0.67 | ELANE (0.51) | ELANEKDM4E | |
| SCHEMBL9407222 | 0.66 | ELANE (0.54) | ELANETDP1 | |
| SCHEMBL9149106 | 0.66 | ELANE (0.82) | ELANETDP1 | |
| SCHEMBL7281962 | 0.63 | ELANE (0.50) | ELANETDP1KDM4E | |
| SCHEMBL7008337 | 0.62 | ELANE (0.50) | ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0626378-B1 | Saccharin derivative proteolytic enzyme inhibitors | SANOFI SYNTHELABO (FR) | 2003-01-22 | — | — | EP | claimed |
| EP-0626378-B1 | Saccharin derivative proteolytic enzyme inhibitors | SANOFI SYNTHELABO (FR) | 2003-01-22 | — | — | EP | disclosed |